Imunon Inc expected to post a loss of 93 cents a share - Earnings Preview
Imunon Inc <IMNN.OQ> expected to post a loss of 93 cents a share - Earnings Preview
Imunon Inc IMNN.OQ IMNN.O is expected to show no change in quarterly revenue when it reports results on August 3 (estimated) for the period ending June 30 2026
LSEG's mean analyst estimate for Imunon Inc is for a loss of 93 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Imunon Inc is $13.00, about 712.5% above its last closing price of $1.60
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | -1.20 | -1.11 | -0.84 | Beat | 24.3 |
Dec. 31 2026 | -1.25 | -1.17 | -1.99 | Missed | -69.5 |
Sep. 30 2025 | -1.87 | -1.81 | -1.16 | Beat | 35.7 |
Jun. 30 2025 | -3.55 | -4.12 | -1.87 | Beat | 54.6 |
Mar. 31 2025 | -4.43 | -4.57 | -3.65 | Beat | 20 |
Dec. 31 2024 | -4.51 | -4.73 | -4.57 | Beat | 3.4 |
Sep. 30 2024 | -5.60 | -5.18 | -4.43 | Beat | 14.5 |
Jun. 30 2024 | -6.65 | -7.09 | -6.65 | Beat | 6.1 |
This summary was machine generated July 31 at 13:15 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)